Evidence map›Paper›PMID 34766143›Full record

ArticleMedComm2021

Insights on the structure-function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies.

Jing-Quan Wang, Qingbin Cui, Zi-Ning Lei, Qiu-Xu Teng, Ning Ji, Lusheng Lin, Zhijun Liu, Zhe-Sheng Chen

Open access · goldAbstract read
In one paragraph

Article in MedComm, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Active Ingredients from Chinese Medicine for Combination Cancer Therapy.International journal of biological sciences · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jing-Quan WangDepartment of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University Queens New York USA.
Qingbin CuiDepartment of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University Queens New York USA.
Zi-Ning LeiDepartment of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University Queens New York USA.
Qiu-Xu TengDepartment of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University Queens New York USA.
Ning JiDepartment of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University Queens New York USA.
Lusheng LinCell Research Center Shenzhen Bolun Institute of Biotechnology Shenzhen China.
Zhijun LiuDepartment of Medical Microbiology Weifang Medical University Weifang China.
Zhe-Sheng ChenDepartment of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University Queens New York USA.
St. John's University · USBeike Biotechnology (China) · CNGuangzhou Medical University · CNWeifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ATP-binding cassette (ABC) transporters superfamily mediates multidrug resistance in cancer by extruding structurally distinct chemotherapeutic agents, causing failure in chemotherapy. Among the 49 ABC transporters, multidrug resistance protein 7 (MRP7 or ABCC10) is relatively new and has been identified as the efflux pump of multiple anticancer agents including

Indexed as

ABCC10ABC transportershomology modelingmolecular dynamicsMRP7

Identifiers

PMID34766143
PMCPMC8491190
OpenAlexW3149987779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.